44 related articles for article (PubMed ID: 22131990)
1. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study.
Ahadi M; Moradi A; Musavinejad L; Movafagh A; Moradi A
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1607-1614. PubMed ID: 32592354
[TBL] [Abstract][Full Text] [Related]
2. HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma.
Raj N; Verma D; Kumar A; Rai P; Rao RN
Discoveries (Craiova); 2018 Dec; 6(4):e83. PubMed ID: 32309603
[No Abstract] [Full Text] [Related]
3. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives.
Roviello G; Polom K; Petrioli R; Marano L; Marrelli D; Paganini G; Savelli V; Generali D; De Franco L; Ravelli A; Roviello F
Tumour Biol; 2016 Jan; 37(1):127-40. PubMed ID: 26566626
[TBL] [Abstract][Full Text] [Related]
5. Clinical management of advanced gastric cancer: the role of new molecular drugs.
De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis.
Gu J; Zheng L; Wang Y; Zhu M; Wang Q; Li X
Tumour Biol; 2014 Jun; 35(6):5315-21. PubMed ID: 24557541
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran.
Sanaat Z; Halimi M; Ghojezadeh M; Pirovi AH; Gharamaleki JV; Ziae AE; Kermani IA
Int J Hematol Oncol Stem Cell Res; 2013; 7(3):15-20. PubMed ID: 24505530
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeted agents for gastric cancer: a step forward towards personalized therapy.
Cidon EU; Ellis SG; Inam Y; Adeleke S; Zarif S; Geldart T
Cancers (Basel); 2013 Jan; 5(1):64-91. PubMed ID: 24216699
[TBL] [Abstract][Full Text] [Related]
9. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor expression is an independent poor prognostic factor for human epidermal growth factor receptor 2 positive gastric cancer.
Hsu JT; Chen TD; Chuang HC; Huang SC; Le PH; Chen TH; Lin CJ; Yeh TS
J Surg Res; 2017 Feb; 208():40-50. PubMed ID: 27993216
[TBL] [Abstract][Full Text] [Related]
12. HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain.
Cidon EU; Centeno RG; Lagarto EG; Peral JI
J Oncol; 2011; 2011():391564. PubMed ID: 22131990
[TBL] [Abstract][Full Text] [Related]
13. Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients.
Hsu JT; Chen TC; Tseng JH; Chiu CT; Liu KH; Yeh CN; Hwang TL; Jan YY; Yeh TS
Oncologist; 2011; 16(12):1706-13. PubMed ID: 22143936
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
Liu W; Zhong S; Chen J; Yu Y
J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
[TBL] [Abstract][Full Text] [Related]
15. [HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].
Wang Y; Xu JM; Liu JZ; Lin L; Ge FJ; Li SS; Liu LJ; Zhao CH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):671-5. PubMed ID: 22340047
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
